worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Investor Relations

Novartis Investor Relations

Quarterly results

Q3 2009

Q3 2009 results - October 22, 2009

YTD 2009
(USD m)
YTD 2008
(USD m)
% change
(USD)
Net sales
31,341
31,382
0 (lc: 8)
Operating income
% of net sales
7,345
23.4%
7,284
23.2%
1
Net income
% of net sales
6,131
19.6%
6,656
21.2%
-8
Basic earnings per share
USD 2.69
USD 2.93
-8

Q3 2009
(USD m)
Q3 2008
(USD m)
% change
(USD)
Net sales
11,086
10,747
3 (lc: 7)
Operating income
% of net sales
2,634
23.8%
2,335
21.7%
13
Net income
% of net sales
2,112
19.1%
2,082
19.4%
1
Basic earnings per share
USD 0.93
USD 0.92
1

Media Release:

 


The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.

SIX

NYSE

 
 
 
 

Corporate publications

Corporate publications

Download our latest financial reports.

2010 key events

Jan 26 - Fourth quarter and full-year 2009 results

Feb 26 - Annual General Meeting

Apr 20 - First quarter 2010 results

Jul 15 - Second quarter and first half 2010 results

Oct 21 - Third quarter and first nine months 2010 results